Global CNS Biomarker Market to Exceed USD 17.89 Billion by 2031, Fueled by Demand for Early Diagnosis and Precision Neurology

[Boston, 4th July 2025] – Clearview Market Insights (CVMI) reports that the global CNS biomarker market will grow from USD 7.93 billion in 2024 to USD 17.89 billion by 2031, with a CAGR of 12.3%. The market is driven by the increasing prevalence of neurological disorders, rising demand for early diagnostics, and advances in precision medicine in neuroscience.

“CNS biomarkers are transforming neurology by facilitating early diagnosis, personalized therapies, and efficient disease monitoring, especially in Alzheimer’s and Parkinson’s disease,” said Dr. Elena Foster, neuroscience analyst at CVMI.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-central-nervous-system-cns-biomarker-market/

Key Market Highlights

  • 2024 Market Size: USD 7.93 billion
  • 2031 Forecast: USD 17.89 billion
  • CAGR: 12.3% (2024–2031)

Growth Catalysts

  • Rise in neurological disorders: Alzheimer's, Parkinson's, MS driving biomarker demand.
  • Precision Medicine: Tailoring treatments based on biomarker insights.
  • Advancements in Omics & Imaging: Growth in liquid biopsy and AI-driven biomarker discovery.

Segment Insights

  • Top Biomarker Type: Diagnostic biomarkers account for over 40% of the share.
  • Fastest-Growing Application: Monitoring drug discovery and clinical trials.
  • Regional Leaders: North America leads, followed by Europe; APAC is the fastest-growing region.

Competitive Overview (2024)

  • Thermo Fisher – 20%: Leader in omics-based CNS biomarker assays.
  • Bio-Rad – 17%: Robust portfolio in multiplex and neurodegenerative biomarkers.
  • Merck – 15%: Focus on proteomics and neurodegeneration kits.
  • Others – 48%: Mix of imaging, omics, and assay providers globally.

Outlook to 2031

The CNS biomarker market will keep growing with the development of AI-integrated biomarker platforms, portable diagnostic devices, and liquid biopsy solutions for neurological diseases. Growth in emerging markets will be driven by increased investments in neuroscience and healthcare infrastructure.

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

161
Sponsored
Search
Sponsored
Sponsored
V
Suggestions

Other
Dysphagia Supplements Market Opportunities, Business Forecast To 2030
The report "Dysphagia Supplements Market by Product Type (Powder thickeners, Instant food, Ready...
By Bhanu 2K
Other
Recruitment Process Outsourcing Market Growth Surges to 16.2% CAGR, USD 20.6 Bn Valuation by 2030
Recruitment Process Outsourcing (RPO) Market Overview: Step into the future of the...
By AutoTechNews 1K
Other
https://www.facebook.com/GlucoFitBootsUK/
╰┈➤Product Name —GlucoFit Reviews UK   ╰┈➤Composition —Natural Organic...
By Dgweywtewrer 1K
Software
AI Chatbot Technology Explained: Key Features, Benefits, and Use Cases
Artificial Intelligence (AI) has transformed various industries, and chatbots are one of the most...
By Shaheeer 990
Fashion
Versatility in Styling: The SP5DER Hoodie
In the world of streetwear, versatility is key. Fashion enthusiasts are constantly on the lookout...
Sponsored
Sponsored
V